Trial
NCT05110781
Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Davis
Collaborators
National Cancer Institute (NCI); Genentech, Inc.
Condition
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
Intervention
Atezolizumab
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-05